| Literature DB >> 29263209 |
Julia Oyrer1, Snezana Maljevic1, Ingrid E Scheffer1, Samuel F Berkovic1, Steven Petrou1, Christopher A Reid2.
Abstract
Epilepsy is a common and serious neurologic disease with a strong genetic component. Genetic studies have identified an increasing collection of disease-causing genes. The impact of these genetic discoveries is wide reaching-from precise diagnosis and classification of syndromes to the discovery and validation of new drug targets and the development of disease-targeted therapeutic strategies. About 25% of genes identified in epilepsy encode ion channels. Much of our understanding of disease mechanisms comes from work focused on this class of protein. In this study, we review the genetic, molecular, and physiologic evidence supporting the pathogenic role of a number of different voltage- and ligand-activated ion channels in genetic epilepsy. We also review proposed disease mechanisms for each ion channel and highlight targeted therapeutic strategies.Entities:
Mesh:
Substances:
Year: 2018 PMID: 29263209 PMCID: PMC5738717 DOI: 10.1124/pr.117.014456
Source DB: PubMed Journal: Pharmacol Rev ISSN: 0031-6997 Impact factor: 25.468